Summary of this article
Gaudium IVF shares listed at Rs 83 on Both NSE and BSE, up 5.06 per cent over Rs 79 issue price
Following the debut, market cap rose to around Rs 604 crore from Rs 485 crore pre issue
The firm plans to use net proceeds for setting up 19 new IVF centres and clearing its debts
Gaudium IVF and Women Health made a positive debut on the stock exchanges on February 27, with the stock listing at a premium to its issue price.
The fertility services provider debuted at Rs 83 apiece on both the NSE and the BSE, a premium of 5.06 per cent over the issue price of Rs 79 per share. In absolute terms, the stock opened Rs 4 higher than the price at which shares were allotted in the IPO.
Ahead of the listing, shares of Gaudium IVF and Women Health were quoting a nil grey market premium (GMP) in the run-up to the debut, according to websites that track such trades, suggesting expectations of a flat-to-marginal listing.
Gaudium IVF IPO allotment status was finalised on February 25. Successful applicants received shares in their demat account on February 26, while unsuccessful ones got refunded on February 25. Gaudium IVF IPO was available to subscribe between February 20 and February 24.
Here’s How Much Investors Made
The company had offered its shares in a price band of Rs 75 to Rs 79 apiece. Investors were required to bid for a minimum lot of 189 shares. At the upper end of the band, retail investors had to invest at least Rs 14,931 for one lot.
With the stock listing at Rs 83, retail investors who received allotment earned a notional gain of Rs 756 per lot at the time of listing.
Gaudium IVF IPO Details, Market Cap
Gaudium IVF and Women Health raised Rs 165 crore through its public issue. It offered a total of 2,08,86,200 equity shares. Of this, 1,13,92,500 shares were issued as a fresh issue to raise Rs 90 crore for the company. The remaining 94,93,700 shares, aggregating Rs 75 crore, came through an offer for sale (OFS), where existing shareholders diluted part of their stake and received the proceeds.
Before the issue, the company had 6,13,94,384 shares outstanding. After the fresh issue of shares, the total equity base expanded to 7,27,86,884 shares.
At the issue price of Rs 79 per share, Gaudium IVF’s market capitalisation stood at around Rs 485 crore before listing and before the issue of new shares. Following the debut at Rs 83, the company’s market capitalisation rose to around Rs 604.13 crore.
Gaudium IVF IPO Objectives
The fertility services company plans to use the Rs 90 crore net proceeds for setting up 19 new IVF centres. According to its red herring prospectus (RHP), it will allocate Rs 50 crore for the same. The company will use another Rs 20 crore to clear its debts and will use the remaining amount for general corporate purposes.
Gaudium IVF IPO Subscription Details
Gaudium IVF and Women Health had reserved up to 50 per cent of the net issue for QIBs. It allocated up to 35 per cent to retail investors and for non-institutional investors (NIIs), the company allocated 15 per cent of the offering.
By the end of the final day of bidding, Gaudium IVF and Women Health IPO was subscribed 7.27 times overall. The QIB portion was booked 1.62 times, NII category saw 14.05 times subscription, while the retail investors' category was booked 7.60 times their quota.
